Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma

Over a decade of sequencing-based genomics research has unveiled a diverse somatic mutation landscape across patients with pancreatic ductal adenocarcinoma (PDAC), and the identification of druggable mutations has aligned with the development of novel targeted therapeutics. However, despite these ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Topham, James T., Renouf, Daniel J., Schaeffer, David F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Liquid Biopsy in Gastrointestinal Cancers: circulating tumor DNA (ctDNA) and circulating tumor cell (CTC)-based precision oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989430/
https://www.ncbi.nlm.nih.gov/pubmed/36895849
http://dx.doi.org/10.1177/17588359231157651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989430/
https://www.ncbi.nlm.nih.gov/pubmed/36895849
http://dx.doi.org/10.1177/17588359231157651

Ejemplares similares